Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

Great question! Carthnel it is my belief that most still do not understand the story that is rapidly unfolding here. Nash Pharmaceuticals, through their blitz of news releases, have told shareholders we have multiple repositioned/repurposed Lead Compounds at play here. Any one of them can lead to multi-billion dollar revenue stream >>> We have NASH Disease (NASH), Inflammatory Bowel Disease (“IBD”), Chronic Kidney Disease (“CKD”), Crohn’s disease (CD), Ulcerative Colitis (UC), Ulcerative Colitis (UC), Unilateral Ureteral Obstruction (UUO), AND some of our Lead Compounds cross over into other potential areas of treatment.

For example see Lead Compound NP-160:

two additional compounds, NP-160 and NP-251 were identified as new lead compounds in a unilateral ureteral obstruction (UUO) mouse model of kidney fibrosis.

...(the “Company” or “Nash Pharma”) is pleased to announce that its lead compound for non-alcoholic steatohepatitis (“NASH”) NP-160 showed repeated positive results in a recently completed study investigating its therapeutic effects in the widely used STAM™ mouse model from SMC Laboratories.

Here's another pearl Nash Pharma dropped on shareholders -

A new potential treatment for CD could lead to an orphan drug designation, which could help expedite its availability to patients. There are a number of countries globally, that have an orphan drug program in place whereby companies that develop drugs for certain rare diseases enjoy enhanced collaboration with the regulatory authority, incentives, marketing exclusivity, and improved pricing and reimbursement.

Having said that, let's go back to your question Carthnel -

When are the phase results due?

I don't have a definitive answer, but I do have an opinion I'd like to share. Here goes >>> According to FDA language, it says a Phase II clinical trial is conducted anywhere from "several months to 2 years". However, here's where I'm trying to go with the matter. I do not think this is a stock to play around with timelines. There's too much going on in the background that could send the stock skyrocketing overnight! Mega deal have been struck @ Phase I of the clinical trial process. We're already beyond that point with multiple potential winners. Furthermore, it's my belief trial progress can be reported on during the trial. It does not need to wait the full duration to report news. There's simply way too many things at play here, and it's still just a friggin penny stock price. Why wait until it's already $5 per share before jumping in for $10 $20 or whatever? As I have stated before, those already holding Cannabix would be crazy not to be holding Breathtec now. Breathtec has the FAIMS technology also remember? Which is another positive news catalyst we all await.

Simply put, I think were finally making a strong move to the upside^

We're done diving head first into...

THE ABYSS



/////AMG

P.S. BTH/CF is a lightening in a bottle HOLD - Period